Search News
| 8.90 Delayed Data As of 12:52pm ET |  +0.0547 / +0.62%Today’s Change | 3.45 Today|||52-Week Range 12.60 | +76.33% Year-to-Date |
| Previous close | 8.85 |
| Today’s open | 8.80 |
| Day’s range | 8.75 - 9.03 |
| Volume | 84,223 |
| Average volume (3 months) | 390,747 |
| Market cap | $490.3M |
| Earnings growth (last year) | +78.45% |
| Earnings growth (this year) | +23.40% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +617.64% |
| P/E ratio | NM |
| Price/Sales | 25.83 |
| Price/Book | 3.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARDXArdelyx Inc | +0.08 | +1.91% |
| DRRXDURECT Corp | +0.04 | +3.08% |
| CPRXCatalyst Pharmaceuti... | +0.01 | +0.35% |
| PETXAratana Therapeutics... | +0.21 | +4.22% |
| Next reporting date | November 8, 2018 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $10.7M |
| Annual profit (last year) | -$84.4M |
| Net profit margin | -788.91% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Mark J. Murray |
Chief Financial Officer David C. Hastings |
Corporate headquarters Burnaby, British Columbia |
